Loading provider…
Loading provider…
Cardiovascular Disease Physician in Doral, FL
NPI: 1174525778Primary Practice Location
Antonio Cano PLLC
8726 NW 26th St, Doral, FL
Primary Employer
Antonio Cano PLLC
antoniocanoperello.es
HQ Phone
Get MD Antonio's Phone Numberphone_androidMobile
Get MD Antonio's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2005 - 2027
TX State Medical License
2003 - 2004

American Board of Internal Medicine
Cardiovascular Disease

American Board of Internal Medicine
Interventional Cardiology
Mount Sinai Medical Center of Florida
Fellowship • Interventional Cardiology
2009 - 2010
Fellowship • Cardiovascular Disease
2006 - 2009
Residency • Internal Medicine
1999 - 2002
Autonomous University of San Luis Potosi Faculty of Medicine
Medical School
Until 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 258 | 268 |
| 2 | 93307Chest ultrasound examination of heart | 35 | 39 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 25 | 25 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 23 | 53 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 16 | 31 |
The impact of coffee on health.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Planta Med
Publication Date: 2017-07-04
Authors: Cano, Antonio, Rees, Margaret, Simoncini, Tommaso
Journal: Maturitas
Publication Date: 2017-09-08
The action of estrogens and progestogens in the young female breast.
Authors: Irene Zolfaroli, Juan J. Tarín, Antonio Cano
Publication Date: 2018-11
Lead Sponsor: University of Valencia
Lead Sponsor: Laboratorios Casen-Fleet S.L.U.
Collaborators: Apices Soluciones S.L., Asociacion Colaboracion Cochrane Iberoamericana
Intervention / Treatment: DRUG: Placebo, DRUG: Soy isoflavones (Glycine max L) and red clover extract (Trifolium pretense L)
Lead Sponsor: University of Valencia
Intervention / Treatment: DRUG: Raloxifene, DRUG: Strontium ranelate